The Renal Safety in Patients With Chronic HCV Undergoing Sofosbuvir Containing Antiviral Therapy
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate the occurrence of AKI during antiviral therapy, when
compared with baseline values in Egyptian patients.
In addition, the study aims to evaluate the change in insulin resistance value after treating
patients from HCV.